168 related articles for article (PubMed ID: 38756638)
1. Solute carrier family 16 member 1 as a potential prognostic factor for pancreatic ductal adenocarcinoma and its influence on tumor immunity.
Wang M; Liu L; Li X; Jiang W; Xiao J; Hao Q; Wang J; Reddy AV; Talbot A; Ikuta S; Tian D; Ren L
J Gastrointest Oncol; 2024 Apr; 15(2):730-746. PubMed ID: 38756638
[TBL] [Abstract][Full Text] [Related]
2. Solute carrier transporter superfamily member SLC16A1 is a potential prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma.
Xie J; Zhu Z; Cao Y; Ruan S; Wang M; Shi J
Channels (Austin); 2021 Dec; 15(1):483-495. PubMed ID: 34254872
[TBL] [Abstract][Full Text] [Related]
3. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma.
Luan H; Zhang C; Zhang T; He Y; Su Y; Zhou L
Dis Markers; 2020; 2020():8825997. PubMed ID: 32934754
[TBL] [Abstract][Full Text] [Related]
4. Identification of solute carrier family genes related to the prognosis and tumor-infiltrating immune cells of pancreatic ductal adenocarcinoma.
Meng Y; Li Y; Fang D; Huang Y
Ann Transl Med; 2022 Jan; 10(2):57. PubMed ID: 35282128
[TBL] [Abstract][Full Text] [Related]
5. The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma.
Wang D; Cui SP; Chen Q; Ren ZY; Lyu SC; Zhao X; Lang R
BMC Cancer; 2023 Jun; 23(1):601. PubMed ID: 37386391
[TBL] [Abstract][Full Text] [Related]
6. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
[TBL] [Abstract][Full Text] [Related]
7. Necroptosis-Related Prognostic Model for Pancreatic Carcinoma Reveals Its Invasion and Metastasis Potential through Hybrid EMT and Immune Escape.
Liu H; Li Z; Zhang L; Zhang M; Liu S; Wang J; Yang C; Peng Q; Du C; Jiang N
Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371833
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma.
Cai W; Bao W; Chen S; Yang Y; Li Y
Cancer Cell Int; 2021 Dec; 21(1):698. PubMed ID: 34930261
[TBL] [Abstract][Full Text] [Related]
9. LDHA is a prognostic biomarker on the immune response in pancreatic adenocarcinoma and associated with m6A modification.
Tan Z; Liu J; Xu J; Zhang B; Yu X; Wang W; Liang C
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4853-4865. PubMed ID: 36269388
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K
Front Immunol; 2021; 12():800268. PubMed ID: 34956238
[TBL] [Abstract][Full Text] [Related]
11. Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma.
Song W; He X; Gong P; Yang Y; Huang S; Zeng Y; Wei L; Zhang J
Front Genet; 2021; 12():639246. PubMed ID: 34249078
[No Abstract] [Full Text] [Related]
12. Analysis of Immune-Related Signatures Related to CD4+ T Cell Infiltration With Gene Co-Expression Network in Pancreatic Adenocarcinoma.
Tan Z; Lei Y; Zhang B; Shi S; Liu J; Yu X; Xu J; Liang C
Front Oncol; 2021; 11():674897. PubMed ID: 34367961
[TBL] [Abstract][Full Text] [Related]
13. Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma.
Huang X; Zhao L; Jin Y; Wang Z; Li T; Xu H; Wang Q; Wang L
Front Oncol; 2022; 12():827051. PubMed ID: 35433491
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
Front Genet; 2022; 13():919638. PubMed ID: 35783277
[No Abstract] [Full Text] [Related]
15. A novel refined pyroptosis and inflammasome-related genes signature for predicting prognosis and immune microenvironment in pancreatic ductal adenocarcinoma.
Zuo J; Yi C; Chen Z; Zhou B; Yang T; Lin J
Sci Rep; 2022 Nov; 12(1):18384. PubMed ID: 36319832
[TBL] [Abstract][Full Text] [Related]
16. IL2RA is a prognostic indicator and correlated with immune characteristics of pancreatic ductal adenocarcinoma.
Fan L; Wang X; Chang Q; Wang Y; Yang W; Liu L
Medicine (Baltimore); 2022 Oct; 101(42):e30966. PubMed ID: 36281157
[TBL] [Abstract][Full Text] [Related]
17. Development and Verification of a novel cuproptosis- and immune-associated based prognostic genetic signature for pancreatic ductal adenocarcinoma.
Xu X; Liang JH; Xu QC; Yin XY
Clin Res Hepatol Gastroenterol; 2023 Mar; 47(3):102089. PubMed ID: 36707046
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of an Autophagy-related Gene Signature in Pancreatic Ductal Adenocarcinoma.
Liu WS; Feng YX; Li SN; Shao YJ; Wang K
Am J Clin Oncol; 2022 Mar; 45(3):95-104. PubMed ID: 35195559
[TBL] [Abstract][Full Text] [Related]
20. Oligoadenylate synthetases-like is a prognostic biomarker and therapeutic target in pancreatic ductal adenocarcinoma.
Chen S; Sun Z; Zhao W; Meng M; Guo W; Wu D; Shu Q; Chai J; Wang L
Ann Transl Med; 2022 Feb; 10(3):138. PubMed ID: 35284540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
